文献速递其他结缔组织病

BAFF抑制与B细胞清除在非肥胖糖尿病小鼠作为干燥病自发模型中的疗效

Efficacy of BAFF inhibition and B-cell depletion in non-obese diabetic mice as a spontaneous model for Sjögren's disease.
PubMed 文献 · RMD Open · 2024-08-28

研究在10至18周龄雌性NOD小鼠(干燥病自发模型)中评估BAFF阻断单克隆抗体Sandy-2对干燥及唾液腺淋巴细胞浸润的疗效;BAFF抑制显著减少唾液腺淋巴细胞浸润且与唾液流率呈负相关,并降低唾液腺、血液、淋巴结和脾的B细胞数量,增加唾液腺Foxp3+调节性T细胞和CD3+CD4-CD8-双阴性T细胞数量;作者结论为该抗体在NOD小鼠模型中具有治疗有效性,调节性T淋巴细胞群增加可能介导该疗效。

要点

  • BAFF抑制显著减少NOD小鼠唾液腺淋巴细胞浸润,且与唾液流率呈负相关。
  • 治疗显著降低唾液腺、血液、淋巴结和脾的B细胞数量。
  • 治疗增加唾液腺Foxp3+调节性T细胞和CD3+CD4-CD8-双阴性T细胞数量。

核心结论

  • 阻断BAFF并清除B细胞的单克隆抗体在NOD小鼠干燥病模型中具有治疗有效性。
  • 调节性T淋巴细胞群增加可能介导该治疗的有效性。

研究设计与样本

  • 研究为动物实验,使用10至18周龄雌性NOD小鼠(干燥病自发模型)。
  • 小鼠接受BAFF阻断单克隆抗体Sandy-2或同型对照治疗。
  • 干燥程度通过刺激后唾液流率测量,唾液腺淋巴细胞浸润通过免疫组化评估。
  • 血液、唾液腺、脾和淋巴结淋巴细胞亚群通过流式细胞术分析,唾液腺mRNA表达通过转录组分析。

主要发现

  • BAFF抑制显著减少唾液腺淋巴细胞浸润,且该浸润与唾液流率呈负相关。
  • 治疗显著降低唾液腺、血液、淋巴结和脾中的B细胞数量。
  • 治疗增加唾液腺中Foxp3+调节性T细胞和CD3+CD4-CD8-双阴性T细胞数量。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: The therapeutic interest of targeting B-cell activating factor (BAFF) in Sjögren's disease (SjD) can be suspected from the results of two phase II clinical trials but has not been evaluated in an animal model of the disease. We aimed to evaluate the therapeutic efficacy of this strategy on dryness and salivary gland (SG) infiltrates in the NOD mouse model of SjD. MATERIAL AND METHODS: Female NOD mice between ages 10 and 18 weeks were treated with a BAFF-blocking monoclonal antibody, Sandy-2 or an isotype control. Dryness was measured by the stimulated salivary flow. Salivary lymphocytic infiltrates were assessed by immunohistochemistry. Blood, SGs, spleen and lymph-node lymphocyte subpopulations were analysed by flow cytometry. SG mRNA expression was analysed by transcriptomic analysis. RESULTS: BAFF inhibition significantly decreased SG lymphocytic infiltrates, which was inversely correlated with salivary flow. The treatment markedly decreased B-cell number in SGs, blood, lymph nodes and spleen and increased Foxp3+ regulatory and CD3+CD4-CD8- double negative T-cell numbers in SGs. CONCLUSION: A monoclonal antibody blocking BAFF and depleting B cells had therapeutic effectiveness in the NOD mouse model of SjD. The increase in regulatory T-lymphocyte populations might underlie the efficacy of this treatment.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. Felten R, Foray AP, Schneider P, et al. Efficacy of BAFF inhibition and B-cell depletion in non-obese diabetic mice as a spontaneous model for Sjögren's disease. RMD Open. 2024. PMID: 39209370. doi:10.1136/rmdopen-2024-004112

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。